MediciNova, Inc.

NASDAQ:MNOV

Biotechnology

Healthcare
$1.27 -1.32%

-$0.02 today

Market cap
$65.07M
Beta
0.62
P/E (TTM)
-5.6
EPS (TTM)
-$0.24
52W Low $1.17High $1.96

Volume 0.09M

Average 0.04M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$9.81M

FY 2025 · Annual

Investing Cash Flow

-$2,899.00

FY 2025 · Annual

Financing Cash Flow

$244,018.00

FY 2025 · Annual

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(10.13M)(14.07M)(8.57M)(11.05M)(12M)
Depreciation & Amortization26.15K17.71K20.3K21.08K20.1K
Deferred Income Tax00000
Stock-Based Compensation1.72M642.52K710.71K1.19M829.1K
Change in Working Capital(1.21M)334.1K111.99K(979.56K)1.17M
Accounts Receivables00000
Inventory00000
Accounts Payables(1.03M)329.01K19.24K(312.35K)459.87K
Other Working Capital(181.42K)5.09K92.75K(667.21K)705.15K
Other Non-Cash Items216.93K163.19K297.49K173.32K173.68K
Operating Cash Flow(9.38M)(12.91M)(7.43M)(10.64M)(9.81M)
Capital Expenditures(28.73K)(5.01K)(21.3K)(895)0
Acquisitions (Net)05.01M000
Purchases of Investments0(59.88M)000
Sales of Investments019.88M39.93M00
Other Investing Activities0(5.01M)0198(2.9K)
Investing Cash Flow(28.73K)(40.01M)39.91M(697)(2.9K)
Debt Repayment00000
Common Stock Issued20.89M7.92K000
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(112.26K)000244.02K
Financing Cash Flow20.78M7.92K00244.02K
Effect of Forex Changes26.55K(16.81K)17.27K3.96K15.68K
Net Change in Cash11.39M(52.93M)32.49M(10.64M)(9.55M)
Free Cash Flow(9.41M)(12.92M)(7.45M)(10.64M)(9.81M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$12.0M
+ D&A$20.1K
+ Stock-Based Comp$829.1K
+ Deferred Tax$0
+ Working Capital$1.2M
+ Other Non-Cash$173.7K
= Operating Cash Flow-$9.8M
- Capex$0
= Free Cash Flow-$9.8M

Analysis

FY2025 free cash flow is -$9.8M. FCF conversion is 81.8% of net income. Operating cash flow was -$9.8M, with capex of $0. The largest bridge item is Working Capital at $1.2M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
10-QQuarterly reportNov 12, 2026
SC 13GSC 13G filingOct 30, 2026
4Statement of changes in beneficial ownershipSep 29, 2026
SC 13D/ASC 13D/A filingSep 29, 2026
8-KCurrent reportSep 28, 2026

Does MNOV generate free cash flow?

MediciNova, Inc. (MNOV) generated -$9.81M of free cash flow in fiscal 2025.

How much operating cash flow does MNOV produce?

Operating cash flow was -$9.81M, before capital expenditures of $0.00.